poisar

Economy · News reference

Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%

BenzingaPiero Cingari

Stocks fell and small caps slumped Wednesday as the 30-year Treasury yield hit 5.7%, a 24-year high, with Fed minutes and bond auctions ahead.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolStefon Walters

    If I Were Investing My First $1,000 Today, This Is the ETF I'd Buy and Hold for Decades

    The article recommends the Vanguard S&P 500 ETF (VOO) as an ideal first investment for beginners with $1,000. VOO offers diversification across all major U.S. sectors, has a low expense ratio of 0.03%, and has delivered an average annual return of 12.4% since inception. The S&P 500 is presented as a reliable, long-term investment strategy that requires minimal effort and decision-making.

  2. The Motley FoolJohn Ballard

    A Bear Market Is Coming Eventually. History Says This Is the Best Investing Move You Can Make.

    While bear markets are inevitable and occur roughly every 3.5 years on average, history shows that staying fully invested and maintaining a consistent investment schedule is more profitable than trying to time the market. Missing just a few of the market's best days can significantly reduce long-term returns, making patient, disciplined investing the optimal strategy for building wealth.

  3. Globenewswire IncDelveinsight

    NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight

    The non-small cell lung cancer market is shifting toward precision, biomarker-guided treatment sequencing. ESMO 2026 presented Phase III data showing savolitinib plus osimertinib improved survival in MET-altered EGFR-mutated NSCLC, divarasib outperformed approved KRAS G12C inhibitors, and TROP2-directed ADCs demonstrated durable gains. The 7MM NSCLC market is projected to double from USD 33 billion in 2025 to USD 67 billion by 2036, driven by expanded screening, biomarker-driven therapies, and label expansions into earlier-stage disease.

  4. Zacks Investment ResearchNa

    Following Goldman Sachs & UBS? Bet on S&P 500 ETFs for 2027

    Goldman Sachs and UBS project the S&P 500 will rise to 8,700-8,900 by 2027, supported by strong economic growth, attractive valuations following recent market corrections, and continued earnings growth despite expected slowdown. The U.S. economy expanded 3.4% in Q3 2026, and consumer sentiment improved, suggesting robust spending ahead. However, concerns remain over AI regulation, elevated inflation, and potential Fed hawkishness.

  5. Globenewswire IncPrecedence Research

    Pharmaceutical Market to Reach USD 3.20 Trillion by 2035 as Obesity and Oncology Drugs Lead Growth and U.S. Pricing Deals and Tariffs Reshape Manufacturing

    The global pharmaceutical market is valued at USD 1.88 trillion in 2026 and is projected to reach USD 3.20 trillion by 2035 at a CAGR of 6.10%. Growth is concentrated in obesity and oncology therapies, with U.S. pricing deals and Section 232 tariffs reshaping manufacturing. North America holds 42% of the market, while companies with strong positions in GLP-1 medicines and cancer therapies are growing significantly faster than the market.